Showing results (1001-1010 of 9,901) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|December 20, 2016
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patientsB S Andersson, P F Thall, B C Valdez, et al.
Bone Marrow Transplantation|July 1, 1989
Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host diseaseG Laurent, D Maraninchi, E Gluckman, et al.
Bone Marrow Transplantation|September 1, 1989
Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantationM C Favrot, D Floret, S Negrier, et al.
Bone Marrow Transplantation|September 1, 1989
An immunotoxin system intended for bone marrow purging composed of glucose oxidase and lactoperoxidase coupled to monoclonal antibody 097H O Ito, J Morizet, L Coulombel, et al.
Bone Marrow Transplantation|November 15, 2016
Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patientsR Oostvogels, E Kneppers, M C Minnema, et al.
Bone Marrow Transplantation|October 4, 2016
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009S Rosengren, U-H Mellqvist, H Nahi, et al.
Bone Marrow Transplantation|January 24, 2017
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow TransplantationJ Schetelig, L C de Wreede, M van Gelder, et al.
Bone Marrow Transplantation|January 24, 2017
Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)C Roux, K Tifratene, G Socié, et al.
Bone Marrow Transplantation|January 24, 2017
Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCTP Esser, K Kuba, A Mehnert, et al.
Bone Marrow Transplantation|August 28, 2003
Ex vivo expansion of autologous PB CD34+ cells provides a purging effect in children with neuroblastomaJ Kanold, P Halle, A Tchirkov, et al.
Pageof 991